Advisory Board

enterade® is inextricably intertwined with the medical community. To make certain all research protocols and product development aligns with medical findings and meets with established research requirements, we formed an advisory board of scientific and medical experts and industry opinion leaders.

Henry J. Binder, MD

  • Chairman of the Scientific Advisory Board, Yale School of Medicine
  • Advisory Board and Professor Emeritus of and Senior Research Scientist in Medicine (Digestive Diseases)

Jervoise Andreyev, MD, PhD

  • Royal London Hospital
  • PHD in molecular biology from the Institute of Cancer Research
  • First gastroenterologist appointed specifically to treat the side effects of cancer treatments

Olivier Fontaine, MD, MS, FACP

  • Medical Officer for World Health Organization in the Diarrheal Diseases Control Program
  • MD, University Paris V
  • MS in Molecular Biology, University Paris VI Jussieu

Charles. F. Fuchs, MD, MPH

  • Director of Yale Cancer Center
  • Physician-in-chief at Smilow Cancer Hospital


  • CEO, Cancer Australia
  • Clinical Ambassador for the Transforming Health initiative in SA
  • Professor of Cancer Medicine at the University of Adelaide
  • Senior Medical Oncologist at Royal Adelaide Hospital Cancer Centre
  • Immediate Past-President of the Multinational Association of Supportive Care in Cancer (MASCC)

Neal Matheson

  • Former EVP, Chief Technology Officer (CTO) for the Johnson & Johnson Family of Consumer Companies
  • EVP CTO Unilever

Steven Eric Finkelstein, MD, FACRO

  • Cancer Center Director, BRCC
  • Co-Chair, NRG Immunotherapy Committee and Chair, SWOG Radiation STG Committee
  • Senior Director, ASTRO eContouring and Co-Chair, 2018 ACRO Scientific Program Committee
  • Editor-in-Chief, Contemporary Radiation Oncology and Editor, ASCO Publications

Gerard Hoetmer

  • Former Chief Executive Officer (CEO) for CSM
  • Former SVP Global Supply Chain Unilever